Newer antibiotic agents have greatly extended the range of specific therapy in the group of infec- tious diseases with increasing rapidity. Much of this effort is directed against gram-negative bacilli in which group the Brucellae command a prominent position. Up to the present time the use of therapeutic agents in brucellosis has resulted in a certain measure of success, but with limitations, particularly from the point of view of failure to prevent recurrences.
No takes yet. Share an insight, caveat, or question.
Woodward et al. (1949) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: